Kathleen C. Kerrigan, DO, is an Associate Professor of Oncology at the University of Utah and an investigator at Huntsman Cancer Institute. She specializes in head and neck, thyroid, and lung cancers and serves as principal investigator on multiple Phase I–III clinical trials. Her research focuses on early- and late-phase clinical trials, drug development, and patient-reported outcomes. Dr. Kerrigan is also committed to expanding access to high-quality cancer care and clinical trials across rural and underserved communities in the Intermountain West.